4//SEC Filing
Lafond Kevin G 4
Accession 0001209191-19-002787
CIK 0001107421other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:27 PM ET
Size
7.2 KB
Accession
0001209191-19-002787
Insider Transaction Report
Form 4
Lafond Kevin G
Vice Pres., Treasurer, & CAO
Transactions
- Award
Common Stock
2019-01-06+37,122→ 85,555 total - Award
Employee Stock Option (right to buy)
2019-01-06+58,536→ 58,536 totalExercise: $2.24Exp: 2029-01-06→ Common Stock (58,536 underlying)
Footnotes (2)
- [F1]12,374 shares shall vest on each of 12/31/2019, 12/31/2020 and 12/31/2021.
- [F2]1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2018.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001429559
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:27 PM ET
- Size
- 7.2 KB